Showing 421 - 440 results of 114,187 for search '(( i non decrease ) OR ( 5 ((((wt decrease) OR (we decrease))) OR (a decrease)) ))', query time: 1.58s Refine Results
  1. 421
  2. 422

    Statins impact primary embryonic mouse neural stem cell survival, cell death, and fate through distinct mechanisms by Ross A. Carson (5184512)

    Published 2018
    “…To understand how statins could impact the developing brain, we studied effects of pravastatin and simvastatin on primary embryonic NSPC survival, proliferation, global transcription, and cell fate <i>in vitro</i>. We found that statins dose dependently decrease NSPC expansion by promoting cell death and autophagy of NSPCs progressing through the G1 phase of the cell cycle. …”
  3. 423

    Video_5_Why Does Child Mortality Decrease With Age? Modeling the Age-Associated Decrease in Mortality Rate Using WHO Metadata From 25 Countries.MP4 by Josef Dolejs (5534258)

    Published 2021
    “…The inverse proportion was valid for ATTM in non-European countries with two exceptions.</p><p>Slower or no mortality decrease with age was detected in the first year of life, while the inverse proportion model was valid for the age range (1, 10) years in most of the main chapters of ICD10.…”
  4. 424
  5. 425
  6. 426
  7. 427
  8. 428
  9. 429

    S1 Data - by Richard Junior Zapata Dongo (17912565)

    Published 2025
    “…Finally, when ABT-199 was combined with ALKi, we observed a wide range of synergistic effects in the WT and G1202R cell models, while the C1156Y and L1196M models showed limited synergy. …”
  10. 430
  11. 431

    Phenethyl isothiocyanate activates leptin signaling and decreases food intake by Miho Yagi (5921252)

    Published 2018
    “…Leptin is a weight-reducing hormone produced by adipose tissue, which decreases food intake <i>via</i> hypothalamic leptin receptors (Ob-Rb) and the Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) signaling pathway. …”
  12. 432
  13. 433
  14. 434

    Combination metabolic therapy decreases VM-M3 cell proliferation <i>in vitro</i>. by A. M. Poff (752552)

    Published 2015
    “…(p<0.05; one-way ANOVA). Cells receiving combination therapy had a significant decrease in proliferation compared to cells treated with LG only at 24, 48, and 72 hours, and compared to βHB only at 48, 72, and 96 hours, and exhibited a non-significant trend of decreased proliferation compared to LG + HBOT treated cells for the duration of the growth curve. …”
  15. 435
  16. 436
  17. 437
  18. 438
  19. 439
  20. 440